Skip to main content
The American Journal of Clinical Nutrition logoLink to The American Journal of Clinical Nutrition
. 2022 Apr 5;116(2):325–334. doi: 10.1093/ajcn/nqac087

Prospective study of breakfast frequency and timing and the risk of incident type 2 diabetes in community-dwelling older adults: the Cardiovascular Health Study

Allie S Carew 1,2,3, Rania A Mekary 4, Susan Kirkland 5,6,7, Olga Theou 8,9,10, Ferhan Siddiqi 11,12, Robin Urquhart 13,14, Michelle George 15, Chris Blanchard 16,17, Mary L Biggs 18, Luc Djoussé 19,20, Kenneth J Mukamal 21,22, Leah E Cahill 23,24,25,
PMCID: PMC9348984  PMID: 35380627

ABSTRACT

Background

No evidence-based recommendations regarding optimal breakfast frequency and timing and type 2 diabetes mellitus (T2DM) exist for older adults because of limited studies.

Objectives

We sought to prospectively assess relations between breakfast frequency and timing and T2DM risk among older adults and determine whether these depended on sex or cardiometabolic risk factors.

Methods

Weekly breakfast frequency and usual daily breakfast time were assessed by questionnaire at baseline in 3747 older adults (aged ≥ 65 y) from the Cardiovascular Health Study (CHS) who were free of cancer and T2DM and followed for 17.6 y. Multivariable-adjusted hazard ratios (aHRs) with 95% CIs estimated from Cox proportional hazards models were used to quantify associations with T2DM.

Results

Most CHS participants (median age: 74 y; IQR: 71–78 y) consumed breakfast daily (85.5%), and 73% had their first daily eating occasion between 07:00 and 09:00, both of which were associated with higher socioeconomic status, factors that are indicative of a healthier lifestyle, and lower levels of cardiometabolic risk indicators at baseline. During follow-up, 547 T2DM cases were documented. No strong evidence was observed linking breakfast frequency and risk of T2DM. Compared with participants whose breakfast timing (first eating occasion of the day) was 07:00–09:00, those who broke fast after 09:00 had an aHR for T2DM of 0.71 (95% CI: 0.51, 0.99). This association was present in participants with impaired fasting glucose at baseline (aHR: 0.61; 95% CI: 0.39, 0.95) but not in those without (aHR: 0.83; 95% CI: 0.50, 1.38). No associations between eating frequency or timing and T2DM were observed within other prespecified subgroups.

Conclusions

Eating breakfast daily was not associated with either higher or lower risk of T2DM in this cohort of older adults, whereas a later (after 09:00) daily first eating occasion time was associated with lower T2DM risk in participants with impaired fasting glucose at baseline.

This trial was registered at clinicaltrials.gov as NCT00005133.

Keywords: type 2 diabetes mellitus, epidemiology, nutrition, prevention, breakfast frequency and timing, older adults


See corresponding editorial on page 293.

Introduction

Older adults (aged ≥65 y) have the highest prevalence of type 2 diabetes mellitus (T2DM) of any age group (1), and the number of cases among this age group is projected to increase by >4.5-fold from 2005 to 2050 (2). Older adults with T2DM are at substantial risk of developing acute and chronic complications such as geriatric syndromes, kidney disease, major lower-extremity amputation, blindness, stroke, and incident coronary artery disease (3–6), and are at higher risk of institutionalization (7) and premature death (1, 8) than older adults without T2DM. Given these long-term complications, the reduced quality of life, the associated high health care costs, and the rising incidence and prevalence of T2DM (2, 9), T2DM among older adults has become a major challenge in both the clinical and public health realms, making prevention a priority.

Diet is one of the most important modifiable risk factors associated with T2DM in North America (10–13). However, no evidence-based recommendations exist for older adults regarding the timing and/or frequency of meals, snacks, and caloric beverages for cardiometabolic protection because of limited studies on the topic. Breakfast eating timing and frequency have been linked with several cardiometabolic risk factors in the general population such as ghrelin secretion (14), weight gain (15–18), dyslipidemia (19, 20), blood pressure (21), and insulin resistance (19, 20); however, the long-term effect of breakfast eating timing and frequency patterns on new-onset T2DM risk remains unclear. Previous systematic reviews and meta-analyses of 10 observational studies reported that skipping breakfast was associated with significantly increased risk of T2DM in adults aged 14–99 y after comprehensive adjustment for demographic, diet, and lifestyle factors (22, 23), yet no studies assessed breakfast timing (the timing of the first eating occasion of the day when a person breaks fast). None of the included studies were conducted exclusively in older adults; therefore, it remains unknown whether these findings are generalizable to older adults. Further, the associations that have been observed to date are modest (22, 23) and require replication in additional cohorts representing socioeconomic diversity. We previously reported in younger adults that skipping meals to lose weight was associated with increased risk of T2DM in some subgroups characterized by sex and cardiometabolic risk factors (24), but it remains unknown whether any potential relations between the specific meal of breakfast's frequency/timing and the long-term risk of incident T2DM similarly depend on sex and common cardiometabolic risk indicators (BMI and impaired fasting glucose) in older adults.

The objectives of our present study were to 1) characterize the breakfast frequency and timing patterns of a cohort of older, community-dwelling American adults; 2) prospectively determine whether these breakfast frequency and timing patterns were associated with risk of incident T2DM; and 3) test whether this association depended on sex or common cardiometabolic risk factors at baseline [BMI (in kg/m2) ≥30 and impaired fasting glucose].

Methods

Data source and study population

The Cardiovascular Health Study (CHS; NCT00005133) is a population-based, observational, prospective cohort study initiated by the National Heart, Lung, and Blood Institute to identify risk factors related to the development and progression of coronary heart disease and stroke in US adults aged 65 y and older. The design, recruitment, and methods have been reported previously (25). Briefly, 5201 community-dwelling, ambulatory males and females aged 65 y and older from 4 US communities (Forsyth County, NC; Sacramento County, CA; Washington County, MD; and Pittsburgh, PA) were recruited between 1989 and 1990 from randomly generated Health Care Financing Administration Medicare eligibility lists. To increase representation of the black community, a supplemental cohort of 687 predominantly black participants was recruited and enrolled between 1992 and 1993 using similar methods from 3 of the original centers.

Baseline assessments consisted of home interviews and in-clinic evaluations, where standardized physical examinations, blood sampling, diagnostic testing, and questionnaires were conducted by trained personnel to determine the health status, medical history, medication use, and lifestyle habits of participants. Participants attended in-clinic evaluations annually and were contacted by telephone at 6-mo intervals between 1989 and 1999. Semiannual follow-up was continued by telephone after 1999 to ascertain health status and events information. To supplement routine follow-up on incident T2DM, data from the CHS were linked to Centers for Medicare and Medicaid Services (CMS) claims data from 1991 until 2010 using participants’ Social Security number, sex, and date of birth (26, 27). For the present study, we considered the 1992–1993 visit as the baseline assessment to allow for the inclusion of CMS claims data for identification of incident T2DM in the follow-up period. Each center's institutional review board reviewed and approved the study protocol, and all participants gave written informed consent. Institutional review board approval was obtained for the present analyses at the Nova Scotia Health Authority.

In this present analysis, participants were excluded (in this order) if they were deceased by the 1992–1993 visit (n = 354), had prevalent diabetes at baseline (n = 916), their baseline diabetes status was missing (n = 108), they were lost to follow-up in the CHS (n = 624), did not answer the eating timing and frequency questions (n = 21), had cancer (except nonmelanoma skin cancer) during the 5 y preceding baseline (n = 100), or if their follow-up data on incident diabetes were missing (n = 18). We excluded participants with a history of cancer because these participants may have changed their eating timing and frequency patterns owing to health concerns, treatment, treatment side effects, or symptoms. After exclusions, 3747 participants were available for the breakfast frequency analysis (Supplemental Figure 1). Of the 3747 participants included in the breakfast frequency analysis, 3 participants did not answer the question on breakfast timing and were excluded from this analysis. Therefore, 3744 participants were available for the breakfast timing analysis.

Eating timing and frequency and other dietary assessment

A nutrition history questionnaire was used to ascertain information on breakfast frequency, meal frequency, after-dinner snacking, fruit and vegetable intake, breakfast timing, and evening food and drink consumption timing at the baseline visit for both cohorts. Participants were asked to respond to the following questions: “How often do you eat breakfast? Every day, some days, rarely, weekends only, never,” “On Monday through Friday how many meals do you usually eat per day?,” “On Monday through Friday how many snacks do you eat after dinner?,” “About how many servings of vegetables do you eat per day or week, not counting salad or potatoes?,” “How many fruits do you usually eat per day or per week, not counting juices?,” “On Monday through Friday about what time do you usually first eat or drink something after waking up?,” and “On Monday through Friday about what time do you usually last eat or drink something before going to bed?” These last 2 questions were used to calculate the time that participants reported “breaking fast” after going to bed and waking up. According to the American Heart Association, a commonly used definition of breakfast in epidemiologic studies is the consumption of food or beverage (excluding water) between 05:00 and 09:00 (28). Because very few participants (1.6%) ate before 05:00, we used the 07:00 cutoff in categorizing the breakfast timing variable (before 07:00; 07:00–09:00; and after 09:00).

Measurement of covariables and cardiometabolic risk factors

Information on age, sex, race, marital status, household income, education, smoking status, alcohol intake, exercise intensity, depressive symptoms, BMI, hypertension, and hypercholesterolemia was collected at the baseline visit. Of note, only 2 options for sex were presented to participants at baseline: female or male. To ascertain information on race, participants were asked to respond to the following prompt: “Please look at this card and tell me which best describes your race: White, Black, American Indian/Alaskan native, Asian/Pacific Islander, Other.” We created a new dichotomous variable for race (largest racial group in the CHS: no, yes) because some categories of the original race variable contained too few participants for analysis. Repeated assessment of demographic characteristics, lifestyle habits, prescription medication use, health conditions, anthropometric measures, and laboratory values occurred during annual study visits. Hypertension was defined in the CHS as seated average systolic blood pressure ≥160 mm Hg or seated average diastolic blood pressure ≥95 mm Hg or use of antihypertensive medication with self-reported history of hypertension. Hypercholesterolemia was defined as total cholesterol ≥240 mg/dL as per the National Cholesterol Education Program Adult Treatment Panel III guidelines (29). Information on prescription medication use during the 2 preceding weeks was collected directly from the medication containers at annual clinic visits in the first 10 y and by semiannual telephone contact thereafter. Fasting glucose was measured at clinic visits in 1989–1990, 1992–1993, 1996–1997, 1998–1999, and 2005–2006; nonfasting glucose was measured in 1994–1995. We created a new dichotomous variable for fasting glucose (<100 mg/dL, ≥100 mg/dL) because a value of ≥100 mg/dL is used to diagnose impaired fasting glucose, which increases an individual's risk of progressing to T2DM (30).

Ascertainment of incident T2DM

Incident T2DM was defined as initiating use of an insulin or oral hypoglycemic medication, measured fasting (≥8 h) glucose ≥126 mg/dL, random (<8 h fasting) glucose ≥200 mg/dL, or the existence of ≥2 inpatient (i.e., hospital, nursing home, or home health services), ≥3 outpatient (outpatient or carrier health services), or ≥1 inpatient and ≥1 outpatient International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) Medicare claim codes for diabetes (prefix 250.xx) over a 2-y period (31). Time-to-incident T2DM was defined as the time in days from the 1992–1993 CHS clinic visit to the earliest of diabetes identified by the CHS data or by CMS records.

Statistical analysis

All statistical analyses were conducted using Stata statistical software version 14.2 (StataCorp LP, 2016), according to an analysis plan developed a priori. All analyses were conducted at a 2-tailed α level of 0.05. We grouped participants based on breakfast frequency pattern (nondaily breakfast consumer: participants who reported eating breakfast “never,” “some days,” “rarely,” or “weekends only”; daily breakfast consumer: “every day”) and breakfast timing pattern (before 07:00, 07:00–09:00, after 09:00) and summarized baseline characteristics, comparing the groups for each breakfast frequency and timing variable using t tests, 1-factor ANOVA, Wilcoxon's rank-sum tests, or Kruskal–Wallis tests for continuous variables (depending on the distribution) and chi-square tests for categorical variables.

To quantify the risk of incident T2DM associated with eating timing and frequency patterns, we used multivariable-adjusted Cox proportional hazards regression models to estimate multivariable-adjusted hazard ratios (aHRs) and 95% CIs. Follow-up time was calculated from the date of the 1992–1993 visit until the date of first diagnosis of T2DM, loss to follow-up, or death, whichever came first; all follow-up was administratively censored in 2010. The proportional hazards assumption was verified using Schoenfeld residuals. In the basic multivariable model 1, we adjusted for age (y) and sex (female, male). In multivariable model 2, we further adjusted for demographic factors: marital status (married, not married), largest racial group in the CHS (no, yes), education (≤high school graduation, >high school graduation), and annual household income (<$25,000, $25,000–$49,999, ≥$50,000). In multivariable model 3, we further adjusted for lifestyle and mental health factors: smoking status (never, former, current), alcohol (number of alcoholic beverages per week: 0, <7, 7–14, >14), exercise intensity (none/low, moderate/high), and depression score [Centre for Epidemiological Studies-Depression Scale (CES-D) score (32, 33); normal: <10; at risk of clinical depression: ≥10 (33)]. In multivariable model 4 (our main model reported for this study), we further adjusted for the dietary factors: fruit and vegetable intake (≥3 servings/d; yes, no), snacks after dinner (yes, no), and meal frequency (<3, ≥3 meals/d). In models in which breakfast timing was the main exposure, we also adjusted for daily breakfast consumption (yes, no). In models in which daily breakfast consumption was the main exposure, we also adjusted for breakfast timing (before 07:00, 07:00–09:00, after 09:00). We examined whether the relations between skipping breakfast and incident T2DM and breakfast timing and incident T2DM depended on sex, BMI, and impaired fasting glucose by conducting subgroup analyses, which were decided upon a priori. Interactions were tested by including interaction terms of the exposure (breakfast frequency or timing) with the cardiometabolic risk factor within the Cox models; however, our a priori objective and power calculations were for a stratified analysis and were potentially not powered for further tests of interaction. To mitigate potential survivor bias, we repeated all analyses excluding participants who were >70 y old at baseline.

BMI is a potential mediator and was continuously adjusted for in subsequent Cox regression models to test whether our results were materially altered by its inclusion, which is a method of examining potential mediation that was previously used (34–37). Assessment of most covariates was repeated over the follow-up period, so we were able to use time-varying covariates in our Cox proportional hazards regression models to assess long-term effects and minimize within-person measurement error. Time-varying covariables were updated at each available time point and the most recent nonmissing values were carried forward if values were missing at subsequent visits. Less than 2% of data were missing for any variable so we conducted complete case analysis.

Results

In this sample of 3747 older American adults without prevalent T2DM, 547 cases of incident T2DM were documented during a median follow-up of 10.7 y (maximum follow-up was 17.6 y). Most participants reported eating breakfast daily (85.5%), whereas few participants (2.8%) reported skipping breakfast daily. At baseline, people who did not consume breakfast daily were younger than those who did consume breakfast daily; were 65.0% females; were more likely to be not in the largest racial group in the CHS (nonwhite); were less educated; were more likely unmarried; had lower annual household income; were more likely to smoke; exercised less intensely; had a higher number of depressive symptoms; had greater fasting glucose, fasting insulin, BMI, and waist circumference; and more often consumed snacks after dinner (Table 1). Participants who did not consume breakfast daily also consumed fewer meals per day and fewer servings of fruits and vegetables per day than participants who did consume breakfast daily. Breakfast timing (breaking fast later than 09:00) was similarly associated with the many baseline variables that have been shown to either increase or decrease risk of T2DM (Table 1).

TABLE 1.

Characteristics of the CHS participants at baseline by breakfast frequency and timing1

Breakfast frequency
Not-daily3 Daily Breakfast timing (first eating occasion of the day2)
Characteristics (0–6 times/wk) (n = 545) (7 times/wk) (n = 3202) P value Before 07:00 (n = 609) 07:00–09:00 (n = 2733) After 09:00 (n = 402) P value
Age, y 73.1 ± 4.6 75.2 ± 5.3 <0.001 74.6 ± 5.3 75.0 ± 5.2 74.5 ± 5.5 0.419
Sex <0.001
 Female 354 (65.0) 1899 (59.3) 0.013 319 (52.4) 1691 (61.9) 242 (60.2)
 Male 191 (35.1) 1303 (40.7) 290 (47.6) 1042 (38.1) 160 (39.8)
Largest racial group in the CHS4 <0.001 <0.001
 No 179 (32.8) 416 (13.0) 83 (13.6) 364 (13.3) 146 (36.3)
 Yes 366 (67.2) 2786 (87.0) 526 (86.4) 2369 (86.7) 256 (63.7)
Education <0.001 <0.001
 ≤High school 342 (63.0) 1655 (51.8) 351 (57.9) 1399 (51.3) 246 (61.4)
 >High school 201 (37.0) 1542 (48.2) 255 (42.1) 1331 (48.8) 155 (38.7)
Household income, US$/y <0.001 <0.001
 <25,000 356 (69.0) 1660 (55.6) 348 (61.3) 1402 (54.9) 263 (70.1)
 25,000–49,999 100 (19.4) 855 (28.6) 142 (25.0) 734 (28.7) 79 (21.1)
 ≥50,000 60 (11.6) 471 (15.8) 78 (13.7) 420 (16.4) 33 (8.8)
Married 313 (57.4) 2226 (69.5) <0.001 390 (64.0) 1906 (69.8) 241 (60.0) <0.001
Smoking status <0.001 0.008
 Never 200 (36.8) 1527 (47.7) 284 (46.6) 1276 (46.7) 167 (41.5)
 Former 242 (44.6) 1396 (43.6) 265 (43.5) 1198 (43.9) 174 (43.3)
 Current 101 (18.6) 278 (8.7) 60 (9.9) 256 (9.4) 61 (15.2)
Alcohol use, drinks/wk 0.154 0.112
 None 265 (48.8) 1700 (53.1) 325 (53.4) 1409 (51.6) 229 (57.3)
 <7 204 (37.6) 1069 (33.4) 189 (31.0) 957 (35.0) 127 (31.8)
 7–14 38 (7.0) 251 (7.8) 58 (9.5) 204 (7.5) 27 (6.8)
 >14 36 (6.6) 180 (5.6) 37 (6.1) 161 (5.9) 17 (4.3)
Exercise intensity 0.022 0.008
 No exercise 65 (11.9) 304 (9.5) 55 (9.0) 259 (9.5) 55 (13.7)
 Low 257 (47.2) 1417 (44.3) 289 (47.5) 1191 (43.6) 193 (48.0)
 Moderate 185 (33.9) 1149 (35.9) 212 (34.8) 995 (36.4) 125 (31.1)
 High 38 (7.0) 332 (10.4) 53 (8.7) 288 (10.5) 29 (7.2)
Hypertension 215 (39.5) 1238 (38.7) 0.728 222 (36.5) 1073 (39.3) 157 (39.1) 0.434
Hypercholesterolemia 109 (20.0) 583 (18.2) 0.309 108 (17.7) 511 (18.7) 73 (18.2) 0.842
Fasting glucose, mg/dL 98.9 ± 10.4 97.6 ± 9.7 0.003 97.5 ± 9.5 97.7 ± 9.9 98.4 ± 10.4 0.101
Fasting insulin, IU/mL 13.4 [10.4–17.4] 12.4 [10.4–16.4] 0.002 12.4 [9.4–15.4] 12.4 [10.4–16.4] 13.4 [10.4–18.4] <0.001
BMI, kg/m2 27.6 ± 5.5 26.2 ± 4.3 <0.001 26.3 ± 4.3 26.3 ± 4.5 27.1 ± 5.3 <0.001
Waist circumference, cm 98.3 ± 14.5 95.7 ± 12.5 <0.001 96.1 ± 13.0 96.0 ± 12.8 96.7 ± 13.4 0.378
CES-D score <0.001 0.019
 Low (<10) 427 (78.4) 2712 (84.7) 523 (85.9) 2295 (84.0) 319 (79.4)
 High (≥10) 118 (21.7) 489 (15.3) 86 (14.1) 437 (16.0) 83 (20.7)
Fruits and vegetables, servings/d <0.001 0.001
 <3 485 (89.8) 2582 (81.1) 482 (79.8) 2227 (82.0) 355 (88.5)
 ≥3 55 (10.2) 601 (18.9) 122 (20.2) 488 (18.0) 46 (11.5)
Breakfast timing <0.001
 Before 07:00 77 (14.2) 532 (16.6)
 07:00–09:00 308 (56.6) 2425 (75.8)
 After 09:00 159 (29.2) 243 (7.6)
Meal frequency, n/d 2.0 ± 0.6 2.8 ± 0.6 <0.001 2.7 ± 0.6 2.7 ± 0.5 2.3 ± 0.6 <0.001
Snacks after dinner 350 (64.9) 1904 (59.9) 0.026 310 (51.5) 1666 (61.3) 275 (69.4) <0.001
1

Values are n (%), mean ± SD, or median [IQR]. Data were analyzed using t tests, 1-factor ANOVA, Wilcoxon's rank-sum tests, or Kruskal–Wallis tests when the dependent variable was continuous (depending on the distribution) and chi-square tests when the dependent variable was categorical. CES-D, Centre for Epidemiological Studies-Depression Scale; CHS, Cardiovascular Health Study.

2

Three participants did not report the usual time of their first eating occasion of the day. Therefore, 3744 participants were included in the breakfast timing analysis.

3

A total of 103 participants reported skipping breakfast daily. Therefore, this group was too small to analyze separately.

4

The largest racial group in our sample of CHS participants was white.

No association was observed between eating breakfast less than daily (never, rarely, weekends only, and some days) and risk of T2DM either before (aHR: 0.92; 95% CI: 0.70, 1.23) or after adjustment for BMI (aHR: 0.89; 95% CI: 0.67, 1.19) (Table 2). Likewise, no association was observed between eating breakfast irregularly (never, rarely, weekends only) and risk of T2DM either before (aHR: 0.74; 95% CI: 0.50, 1.10) or after adjustment for BMI (aHR: 0.73; 95% CI: 0.49, 1.08) as compared with eating breakfast regularly (some days, every day) (Table 3). Similarly, no associations between eating breakfast irregularly and risk of T2DM were observed in the subgroups of males, females, those with BMI <30, with BMI ≥30, with impaired fasting glucose, or without impaired fasting glucose (Table 4).

TABLE 2.

Skipping breakfast and multivariable-adjusted risk of T2DM1

Not-daily breakfast consumer (0–6 times/wk) (n = 545) Daily breakfast consumers (7 times/wk) (n = 3202) P value
T2DM cases, n 82 465
Person-time, y (%) 5762.867 (14.6) 33,694.949 (85.4)
Adjusted for age and sex 1.02 (0.80, 1.30) 1.00 (Referent) 0.879
+ Demographic factors2 0.89 (0.69, 1.15) 1.00 (Referent) 0.390
 + Lifestyle and mental health factors3 0.89 (0.69, 1.15) 1.00 (Referent) 0.373
  + Dietary factors4 0.92 (0.70, 1.23) 1.00 (Referent) 0.587
Additional adjustment for potential mediator
   + BMI5 0.89 (0.67, 1.19) 1.00 (Referent) 0.444
1

Values are HRs (95% CIs) from a multivariable-adjusted analysis using Cox proportional hazards regression unless otherwise indicated. Time-varying covariables were updated at each available time point. T2DM, type 2 diabetes mellitus.

2

In addition to age (y) and sex (female, male), this model adjusted for demographic factors: marital status (married, not married), largest racial group in the Cardiovascular Health Study (no, yes), education (≤high school graduation, >high school graduation), and annual household income (<$25,000, $25,000–$49,999, ≥$50,000).

3

In addition to age, sex, and demographic factors, this model further adjusted for lifestyle and mental health factors: smoking status (never, former, current), alcohol (number of alcoholic beverages per week: 0, <7, 7–14, >14), exercise intensity (none/low, moderate/high), and Centre for Epidemiological Studies-Depression Scale score (high: ≥10; low: <10).

4

In addition to age, sex, demographic, lifestyle, and mental health factors, this model further adjusted for dietary factors: fruit and vegetable intake (3 servings/d; yes, no), breakfast timing (before 07:00, 07:00–09:00, after 09:00), meal frequency (<3, ≥3 meals/d), and snacks after dinner (yes, no). This model is the main model reported for this analysis.

5

In addition to age, sex, demographic, lifestyle, mental health, and dietary factors, this model further adjusted for BMI (kg/m2).

TABLE 3.

Irregular breakfast consumption and multivariable-adjusted risk of T2DM1

Irregular breakfast consumer: rarely, weekends only, never (n = 272) Regular breakfast consumer: every day, some days (n = 3475) P value
T2DM cases, n 36 511
Person-time, y (%) 2908.038 (7.4) 36,549.777 (92.6)
Adjusted for age and sex 0.88 (0.63, 1.23) 1.00 (Referent) 0.452
+ Demographic factors2 0.78 (0.55, 1.11) 1.00 (Referent) 0.170
 + Lifestyle and mental health factors3 0.76 (0.53, 1.08) 1.00 (Referent) 0.124
  + Dietary factors4 0.74 (0.50, 1.10) 1.00 (Referent) 0.135
Additional adjustment for potential mediator
   + BMI5 0.73 (0.49, 1.08) 1.00 (Referent) 0.119
1

Values are HRs (95% CIs) from a multivariable-adjusted analysis using Cox proportional hazards regression unless otherwise indicated. Time-varying covariables were updated at each available time point. T2DM, type 2 diabetes mellitus.

2

In addition to age (y) and sex (female, male), this model adjusted for demographic factors: marital status (married, not married), largest racial group in the Cardiovascular Health Study (no, yes), education (≤high school graduation, >high school graduation), and annual household income (<$25,000, $25,000–$49,999, ≥$50,000).

3

In addition to age, sex, and demographic factors, this model further adjusted for lifestyle and mental health factors: smoking status (never, former, current), alcohol (number of alcoholic beverages per week: 0, <7, 7–14, >14), exercise intensity (none/low, moderate/high), and Centre for Epidemiological Studies-Depression Scale score (high: ≥10; low: <10).

4

In addition to age, sex, demographic, lifestyle, and mental health factors, this model further adjusted for dietary factors: fruit and vegetable intake (3 servings/d; yes, no), breakfast timing (before 07:00, 07:00–09:00, after 09:00), meal frequency (<3, ≥3 meals/d), and snacks after dinner (yes, no). This model is the main model reported for this analysis.

5

In addition to age, sex, demographic, lifestyle, mental health, and dietary factors, this model further adjusted for BMI (kg/m2).

TABLE 4.

Breakfast frequency and multivariable-adjusted risk of type 2 diabetes mellitus stratified by risk factors1

Cases, n Person time, y (%) Not-daily breakfast consumer (0–6 times/wk) P value Daily breakfast consumer (7 times/wk) Interaction P value
Sex 0.431
 Female 340 25,096.986 (63.6) 0.83 (0.58, 1.19) 0.312 1.00 (Referent)
 Male 207 14,360.83 (36.4) 1.11 (0.70, 1.76) 0.661 1.00 (Referent)
Baseline BMI, kg/m2 0.459
 <30 386 32,680.172 (82.9) 0.78 (0.54, 1.12) 0.181 1.00 (Referent)
 ≥30 161 6758.79 (17.1) 1.16 (0.72, 1.86) 0.539 1.00 (Referent)
Baseline impaired fasting glucose 0.995
 No 206 26,695.86 (67.7) 0.74 (0.47, 1.17) 0.198 1.00 (Referent)
 Yes 341 12,761.955 (32.3) 0.98 (0.68, 1.42) 0.933 1.00 (Referent)
1

Values are HRs (95% CIs) from a multivariable-adjusted analysis using Cox proportional hazards regression unless otherwise indicated. Time-varying covariables were updated at each available time point. P values for interaction terms between breakfast frequency and each risk factor were not significant (all interaction P values > 0.43). Models adjusted for age (y), sex (female, male; except when stratified by sex), marital status (married, not married), largest racial group in the Cardiovascular Health Study (no, yes), education (≤high school graduation, >high school graduation), annual household income (<$25,000, $25,000–$49,999, ≥$50,000), smoking status (never, former, current), alcohol (number of alcoholic beverages per week: 0, <7, 7–14, >14), exercise intensity (none/low, moderate/high), Centre for Epidemiological Studies-Depression Scale score (high: ≥10; low: <10), fruit and vegetable intake (3 servings/d; yes, no), breakfast timing (before 07:00, 07:00–09:00, after 09:00), snacks after dinner (yes, no), and meal frequency (<3, ≥3 meals/d).

Approximately 73% of participants broke fast between 07:00 and 09:00. Participants who broke fast after 09:00 had 29% lower risk of T2DM than participants who broke fast between 07:00 and 09:00 after adjustment for demographic, lifestyle, mental health, and dietary factors (aHR: 0.71; 95% CI: 0.51, 0.99) (Table 5). The strength of the evidence was decreased after adjustment for the potential mediator of BMI (aHR: 0.72; 95% CI: 0.51, 1.00). In stratified analyses, among participants with impaired fasting glucose at baseline, those who reported breaking fast after 09:00 had a 39% lower risk of T2DM than those who reported breaking fast between 07:00 and 09:00 (aHR: 0.61; 95% CI: 0.39, 0.95), whereas this association was not significant among participants who did not have impaired fasting glucose at baseline (aHR: 0.83; 95% CI: 0.50, 1.38) (Table 6). No association was observed between breakfast timing and risk of T2DM within the subgroups of sex and baseline BMI.

TABLE 5.

Breakfast timing and multivariable-adjusted risk of T2DM1

Breakfast timing (first eating occasion of the day)
Before 07:00 (n = 609) P value 07:00–09:00 (n = 2733) After 09:00 (n = 402) P value
T2DM cases, n 91 405 51
Person-time, y (%) 6288.493 (16.0) 29,006.667 (73.6) 4126.157 (10.5)
Adjusted for age and sex 1.03 (0.82, 1.30) 0.789 1.00 (Referent) 0.89 (0.66, 1.19) 0.421
+ Demographic factors2 0.99 (0.78, 1.25) 0.939 1.00 (Referent) 0.74 (0.54, 1.01) 0.061
 + Lifestyle and mental health factors3 0.99 (0.79, 1.26) 0.959 1.00 (Referent) 0.72 (0.53, 0.99) 0.042
  + Dietary factors4 1.00 (0.79, 1.27) 0.989 1.00 (Referent) 0.71 (0.51, 0.99) 0.041
Additional adjustment for potential mediator
   + BMI5 1.01 (0.80, 1.28) 0.950 1.00 (Referent) 0.72 (0.51, 1.00) 0.047
1

Values are HRs (95% CIs) from a multivariable-adjusted analysis using Cox proportional hazards regression unless otherwise indicated. Time-varying covariables were updated at each available time point. T2DM, type 2 diabetes mellitus.

2

In addition to age (y) and sex (female, male), this model adjusted for demographic factors: marital status (married, not married), largest racial group in the Cardiovascular Health Study (no, yes), education (≤high school graduation, >high school graduation), and annual household income (<$25,000, $25,000–$49,999, ≥$50,000).

3

In addition to age, sex, and demographic factors, this model further adjusted for lifestyle and mental health factors: smoking status (never, former, current), alcohol (number of alcoholic beverages per week: 0, <7, 7–14, >14), exercise intensity (none/low, moderate/high), and Centre for Epidemiological Studies-Depression Scale score (high: ≥10; low: <10).

4

In addition to age, sex, demographic, lifestyle, and mental health factors, this model further adjusted for dietary factors: fruit and vegetable intake (3 servings/d; yes, no), daily breakfast consumption (yes, no), meal frequency (<3, ≥3 meals/d), and snacks after dinner (yes, no). This model is the main model reported for this analysis.

5

In addition to age, sex, demographic, lifestyle, mental health, and dietary factors, this model further adjusted for BMI (kg/m2).

TABLE 6.

Breakfast timing and multivariable-adjusted risk of type 2 diabetes mellitus stratified by risk factors1

Cases, n Person time, y (%) Before 07:00 (n = 609) P value 07:00–09:00 (n = 2733) After 09:00 (n = 402) P value Interaction P value
Sex 0.744
 Female 340 25,096.986 (63.6) 0.96 (0.69, 1.32) 0.787 1.00 (Referent) 0.74 (0.49, 1.11) 0.144
 Male 207 14,360.83 (36.4) 1.03 (0.73, 1.47) 0.851 1.00 (Referent) 0.71 (0.41, 1.23) 0.217
Baseline BMI, kg/m2 0.776
 <30 386 32,680.172 (82.9) 1.04 (0.79, 1.37) 0.776 1.00 (Referent) 0.70 (0.46, 1.05) 0.086
 ≥30 161 6758.79 (17.1) 0.91 (0.57, 1.47) 0.706 1.00 (Referent) 0.70 (0.41, 1.19) 0.191
Baseline impaired fasting glucose 0.476
 No 206 26,695.86 (67.7) 1.06 (0.72, 1.55) 0.780 1.00 (Referent) 0.83 (0.50, 1.38) 0.475
 Yes 341 12,761.955 (32.3) 0.99 (0.73, 1.34) 0.923 1.00 (Referent) 0.61 (0.39, 0.95) 0.027
1

Values are HRs (95% CIs) from a multivariable-adjusted analysis using Cox proportional hazards regression unless otherwise indicated. Time-varying covariables were updated at each available time point. P values for interaction terms between breakfast timing and each risk factor were not significant (all interaction P values > 0.48). Models adjusted for age (y), sex (female, male; except when stratified by sex), marital status (married, not married), largest racial group in the Cardiovascular Health Study (no, yes), education (≤high school graduation, >high school graduation), annual household income (<$25,000, $25,000–$49,999, ≥$50,000), smoking status (never, former, current), alcohol (number of alcoholic beverages per week: 0, <7, 7–14, >14), exercise intensity (none/low, moderate/high), Centre for Epidemiological Studies-Depression Scale score (high: ≥10; low: <10), fruit and vegetable intake (3 servings/d; yes, no), daily breakfast consumption (yes, no), snacks after dinner (yes, no), and meal frequency (<3, ≥3 meals/d).

Discussion

To the best of our knowledge, the present study is the first to assess whether breakfast frequency and timing patterns are related to an increased risk of T2DM in a large cohort of older males and females (≥65 y of age). The majority of CHS participants consumed breakfast daily and broke fast between 07:00 and 09:00. This pattern was associated with higher socioeconomic status, a healthy lifestyle, and lower levels of cardiometabolic risk indicators. We did not detect an association between eating breakfast daily (breakfast frequency) and risk of T2DM; however, we observed a reduced risk of T2DM among participants who broke fast after 09:00 (breakfast timing), especially among those with baseline impaired fasting glucose.

Our finding that skipping breakfast is cross-sectionally associated with fasting glucose, fasting insulin, BMI, and waist circumference is in alignment with some previous studies that found associations between breakfast frequency and indicators of metabolic and hormonal perturbation (19, 38–40). Although not conducted exclusively in older adults, 1 previous prospective study found that skipping meals to lose weight was associated with several cardiometabolic risk factors at baseline, which is concordant with the present study (24). Our study is also in agreement with previous studies that demonstrated breakfast eaters tend to have a healthier lifestyle and be of higher socioeconomic status (34–37, 41). Of note, the addition of demographic, lifestyle, and dietary factors to the Cox regression models that included age and sex resulted in a change in direction of estimates in addition to a >10% change in estimate size, indicating that the relations between these factors are multidirectional, impactful, and complex.

In a recent meta-analysis of studies on breakfast skipping and T2DM, ever skipping breakfast was associated with an increased risk of T2DM when compared with never skipping breakfast (25). However, unlike the present study, participants in the 6 studies included in the meta-analysis were, on average, middle-aged, and none of the included studies were conducted exclusively in older adults. The first prospective study to examine breakfast consumption and risk of T2DM among females, which was included in the meta-analysis, conducted a sensitivity analysis and found the direct association between irregular breakfast consumption and T2DM risk was observed only among younger females (<65 y of age) and not among older females (≥65 y of age) (Nurses’ Health Study) (36), which is consistent with our findings.

Compared with younger individuals, older adults have reduced individual organ and tissue mass and tissue-specific organ metabolic rate, which contribute to a reduction in resting metabolic rate and, in turn, changes in body composition (42). Therefore, older adults may have different metabolic and nutritional needs, and may differ in rates of glucose metabolism compared with younger individuals, which may partly explain why our results differed from those of studies in younger adults. In addition, CHS participants were older than the traditional age of retirement in the United States at baseline. Reduced work-related stress and improved circadian rhythms in retirement may have had a protective effect against the development of T2DM that outweighed the effect of skipping breakfast (43, 44). In addition, survivor bias may have offset any adverse cardiometabolic effects conferred by eating timing and frequency patterns. However, our sensitivity analysis excluding the oldest participants did not generate materially altered results (data not shown).

To the best of our knowledge, the present study was the first to assess whether breakfast timing was associated with the risk of developing T2DM in any age group. Several possible explanations exist for why breaking fast after 09:00 was associated with a lower risk of T2DM in the present study, including in the subgroup of impaired fasting glucose at baseline. Firstly, the Dawn and Somogyi phenomena may have been present among participants, especially those at cardiometabolic risk (45, 46). Compared with eating later, eating earlier in the morning could have resulted in daily elevated postprandial blood glucose, further disrupting metabolic homeostasis and increasing the risk of T2DM. Secondly, people with metabolic risk factors such as older age, high BMI, and hyperglycemia may have been more likely to adopt practices usually recommended by a dietitian, such as eating breakfast and eating regularly, which could have generated a reverse causation–type effect such as indication bias. Thirdly, confounding by demographic and lifestyle factors that were unmeasured in the CHS, such as sleep duration, may have been present.

Strengths and limitations

The present study included a large sample of older adults and females [who were historically underrepresented in epidemiologic and clinical research (47, 48)], a long duration of follow-up, prospective design, exclusion of prevalent T2DM, a wide range of socioeconomic and health statuses, and comprehensive repeated assessment of various demographic, lifestyle, dietary, and health-related factors, which we were able to control for in our Cox regression models. Including time-dependent factors in our analysis allowed us to minimize misclassification bias and to adjust for time-dependent confounding. We were also able to supplement the follow-up of incident T2DM with CMS claims data to ensure capture was complete. However, the present study had some limitations that should be considered. Breakfast frequency and timing were assessed at 1 point in time and may have changed within the 18-y follow-up period, so we were not able to include time-varying exposures (breakfast frequency and timing) in our analysis, which would have been our ideal method (49–51). As a result, nondifferential misclassification error may have been present, which would have attenuated true associations. Breakfast frequency and timing patterns were self-reported, and interpretation may have differed between participants. To our knowledge, a standard method for assessing meal timing and frequency by questionnaire has not been validated to date. In addition, we did not have details on the composition, quality, or variety of breakfast foods consumed. A limited number of CHS participants reported “never” eating breakfast; thus, we cannot exclude a possible increased risk of T2DM with never eating breakfast in older adults. We also cannot rule out possible residual confounding by unknown or unmeasured factors (e.g., circadian rhythms, light/dark exposure, sleep pattern, food insecurity, and stress). Glucose measures were not available every year, and thus some cases of T2DM may have been missed. Additional prospective longitudinal cohort and clinically based observational studies that enroll participants of diverse ages, genders, races, and ethnic groups in different countries are needed to address the limitations and confirm the findings of the present study.

Conclusions

Our study has provided novel evidence that a later (after 09:00) daily first eating occasion time may be associated with a reduction in long-term risk of incident T2DM among older adults with impaired fasting glucose. However, because the number of cases in the present study was modest and we did not observe a significant interaction P value with impaired fasting glucose, further studies are required to provide clinical evidence and confirmation of the biological mechanism at play. If replicated in other studies in older adults, the findings from our study could be used as evidence in the future when dietary guideline panels develop recommendations for breakfast frequency and timing for older adults.

Supplementary Material

nqac087_Supplemental_File

ACKNOWLEDGEMENTS

We sincerely thank the CHS for providing access to the data.

The authors’ responsibilities were as follows—LEC: conceived the study idea and design, procured the data, had full access to all the data presented, and takes responsibility for the integrity of the data and accuracy of the data analysis; ASC: performed the statistical analyses and drafted the manuscript with LEC and RAM; and all authors: contributed to additional drafts of the manuscript and read and approved the final manuscript. The authors report no conflicts of interest.

Notes

Supported by National Heart, Lung, and Blood Institute (NHLBI) contracts HHSN268201200036C, HHSN268200800007C, HHSN268201800001C, N01HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086, and 75N92021D00006 and grants U01HL080295 and U01HL130114, with additional contribution from the National Institute of Neurological Disorders and Stroke. Additional support was provided by National Institute on Aging grants R01AG023629 and K24AG065525. A full list of principal Cardiovascular Health Study investigators and institutions can be found at https://CHS-NHLBI.org. LEC was supported by a Dalhousie University Internal Medicine Research Foundation Junior Faculty award. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funding sources were not involved in data collection, data analysis, or manuscript drafting.

Supplemental Figure 1 is available from the “Supplementary data” link in the online posting of the article and from the same link in the online table of contents at https://academic.oup.com/ajcn/.

Abbreviations used: aHR, multivariable-adjusted hazard ratio; CHS, Cardiovascular Health Study; CMS, Centers for Medicare and Medicaid Services; T2DM, type 2 diabetes mellitus.

Contributor Information

Allie S Carew, Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada; QEII Health Sciences Centre, Nova Scotia Health Authority, Halifax, Nova Scotia, Canada; Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada.

Rania A Mekary, School of Pharmacy, Massachusetts College of Pharmacy and Health Sciences University, Boston, MA, USA.

Susan Kirkland, Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada; QEII Health Sciences Centre, Nova Scotia Health Authority, Halifax, Nova Scotia, Canada; Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada.

Olga Theou, Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada; QEII Health Sciences Centre, Nova Scotia Health Authority, Halifax, Nova Scotia, Canada; School of Physiotherapy, Dalhousie University, Halifax, Nova Scotia, Canada.

Ferhan Siddiqi, Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada; QEII Health Sciences Centre, Nova Scotia Health Authority, Halifax, Nova Scotia, Canada.

Robin Urquhart, QEII Health Sciences Centre, Nova Scotia Health Authority, Halifax, Nova Scotia, Canada; Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada.

Michelle George, Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada.

Chris Blanchard, Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada; QEII Health Sciences Centre, Nova Scotia Health Authority, Halifax, Nova Scotia, Canada.

Mary L Biggs, Department of Biostatistics, University of Washington, Seattle, WA, USA.

Luc Djoussé, Division on Aging, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA; Department of Nutrition, Harvard TH Chan School of Public Health, Boston, MA, USA.

Kenneth J Mukamal, Department of Nutrition, Harvard TH Chan School of Public Health, Boston, MA, USA; Department of Medicine, Beth Israel Deaconess Medical Center, Brookline, MA, USA.

Leah E Cahill, Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada; QEII Health Sciences Centre, Nova Scotia Health Authority, Halifax, Nova Scotia, Canada; Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada.

Data Availability

Data described in the article, code book, and analytic code will not be made available because the data are not publicly available from the CHS.

References

  • 1. Kirkman MS, Briscoe VJ, Clark N, Florez H, Haas LB, Halter JBet al. Diabetes in older adults. Diabetes Care. 2012;35(12):2650–64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Narayan KM, Boyle JP, Geiss LS, Saaddine JB, Thompson TJ. Impact of recent increase in incidence on future diabetes burden: U.S., 2005–2050. Diabetes Care. 2006;29(9):2114–16. [DOI] [PubMed] [Google Scholar]
  • 3. Corriere M, Rooparinesingh N, Kalyani RR. Epidemiology of diabetes and diabetes complications in the elderly: an emerging public health burden. Curr Diab Rep. 2013;13(6):805–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care. 1979;2(2):120–6. [DOI] [PubMed] [Google Scholar]
  • 5. Pyörälä K, Laakso M, Uusitupa M. Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev. 1987;3(2):463–524. [DOI] [PubMed] [Google Scholar]
  • 6. Stamler J, Vaccaro O, Neaton JD, Wentworth D; The Multiple Risk Factor Intervention Trial Research Group . Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993;16(2):434–44. [DOI] [PubMed] [Google Scholar]
  • 7. Nihtilä EK, Martikainen PT, Koskinen SV, Reunanen AR, Noro AM, Häkkinen UT. Chronic conditions and the risk of long-term institutionalization among older people. Eur J Public Health. 2008;18(1):77–84. [DOI] [PubMed] [Google Scholar]
  • 8. Brown AF, Mangione CM, Saliba D, Sarkisian CA; California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes . Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc. 2003;51(5 Suppl Guidelines):S265–80. [DOI] [PubMed] [Google Scholar]
  • 9. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(1):4–14. [DOI] [PubMed] [Google Scholar]
  • 10. GBD 2016 Mortality Collaborators . Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1084–150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Murray CJL, Atkinson C, Bhalla K, Birbeck G, Burstein R, Chou Det al. The state of US health, 1990–2010: burden of diseases, injuries, and risk factors. JAMA. 2013;310(6):591–608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Schwingshackl L, Hoffmann G, Lampousi A-M, Knüppel S, Iqbal K, Schwedhelm Cet al. Food groups and risk of type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies. Eur J Epidemiol. 2017;32(5):363–75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Carter K, Worwood M. Haptoglobin: a review of the major allele frequencies worldwide and their association with diseases. Int J Lab Hematol. 2007;29(2):92–110. [DOI] [PubMed] [Google Scholar]
  • 14. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes. 2001;50(8):1714–19. [DOI] [PubMed] [Google Scholar]
  • 15. Song WO, Chun OK, Obayashi S, Cho S, Chung CE. Is consumption of breakfast associated with body mass index in US adults?. J Am Diet Assoc. 2005;105(9):1373–82. [DOI] [PubMed] [Google Scholar]
  • 16. van der Heijden AAWA, Hu FB, Rimm EB, van Dam RM. A prospective study of breakfast consumption and weight gain among U.S. men. Obesity (Silver Spring). 2007;15(10):2463–9. [DOI] [PubMed] [Google Scholar]
  • 17. Mattes RD. Snacking: a cause for concern. Physiol Behav. 2018;193(Pt B):279–83. [DOI] [PubMed] [Google Scholar]
  • 18. Barnes TL, French SA, Harnack LJ, Mitchell NR, Wolfson J. Snacking behaviors, diet quality, and body mass index in a community sample of working adults. J Acad Nutr Diet. 2015;115(7):1117–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Farshchi HR, Taylor MA, Macdonald IA. Deleterious effects of omitting breakfast on insulin sensitivity and fasting lipid profiles in healthy lean women. Am J Clin Nutr. 2005;81(2):388–96. [DOI] [PubMed] [Google Scholar]
  • 20. Jenkins DJA, Wolever TMS, Vuksan V, Brighenti F, Cunnane SC, Rao Vet al. Nibbling versus gorging: metabolic advantages of increased meal frequency. N Engl J Med. 1989;321(14):929–34. [DOI] [PubMed] [Google Scholar]
  • 21. Stote KS, Baer DJ, Spears K, Paul DR, Harris GK, Rumpler WVet al. A controlled trial of reduced meal frequency without caloric restriction in healthy, normal-weight, middle-aged adults. Am J Clin Nutr. 2007;85(4):981–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Bi H, Gan Y, Yang C, Chen Y, Tong X, Lu Z. Breakfast skipping and the risk of type 2 diabetes: a meta-analysis of observational studies. Public Health Nutr. 2015;18(16):3013–19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Ballon A, Neuenschwander M, Schlesinger S. Breakfast skipping is associated with increased risk of type 2 diabetes among adults: a systematic review and meta-analysis of prospective cohort studies. J Nutr. 2019;149(1):106–13. [DOI] [PubMed] [Google Scholar]
  • 24. Carew AS, Mekary RA, Kirkland S, Theou O, Siddiqi F, Urquhart Ret al. Prospective study of skipping meals to lose weight as a predictor of incident type 2 diabetes with potential modification by cardiometabolic risk factors: the Canadian 1995 Nova Scotia Health Survey. Can J Diabetes. 2021;45(4):306–12. [DOI] [PubMed] [Google Scholar]
  • 25. Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RAet al. The cardiovascular health study: design and rationale. Ann Epidemiol. 1991;1(3):263–76. [DOI] [PubMed] [Google Scholar]
  • 26. Brutsaert EF, Biggs ML, Delaney JA, Djoussé L, Gottdiener JS, Ix JHet al. Longitudinal assessment of N-terminal pro-B-type natriuretic peptide and risk of diabetes in older adults: the cardiovascular health study. Metabolism. 2016;65(10):1489–97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Joyce KE, Biggs ML, Djoussé L, Ix JH, Kizer JR, Siscovick DSet al. Testosterone, dihydrotestosterone, sex hormone–binding globulin, and incident diabetes among older men: the Cardiovascular Health Study. J Clin Endocrinol Metab. 2017;102(1):33–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. St-Onge M-P, Ard J, Baskin ML, Chiuve SE, Johnson HM, Kris-Etherton Pet al. Meal timing and frequency: implications for cardiovascular disease prevention: a scientific statement from the American Heart Association. Circulation. 2017;135(9):e96–e121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults . Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486–97. [DOI] [PubMed] [Google Scholar]
  • 30. Phillips LS, Weintraub WS, Ziemer DC, Kolm P, Foster JK, Vaccarino Vet al. All pre-diabetes is not the same: metabolic and vascular risks of impaired fasting glucose at 100 versus 110 mg/dl: the Screening for Impaired Glucose Tolerance study 1 (SIGT 1). Diabetes Care. 2006;29(6):1405–7. [DOI] [PubMed] [Google Scholar]
  • 31. Lemaitre RN, Fretts AM, Sitlani CM, Biggs ML, Mukamal K, King IBet al. Plasma phospholipid very-long-chain saturated fatty acids and incident diabetes in older adults: the Cardiovascular Health Study. Am J Clin Nutr. 2015;101(5):1047–54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Carnethon MR, Biggs ML, Barzilay JI, Smith NL, Vaccarino V, Bertoni AGet al. Longitudinal association between depressive symptoms and incident type 2 diabetes mellitus in older adults: the Cardiovascular Health Study. Arch Intern Med. 2007;167(8):802–7. [DOI] [PubMed] [Google Scholar]
  • 33. Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults: evaluation of a short form of the CES-D. Am J Prev Med. 1994;10(2):77–84. [PubMed] [Google Scholar]
  • 34. Cahill LE, Chiuve SE, Mekary RA, Jensen MK, Flint AJ, Hu FBet al. Prospective study of breakfast eating and incident coronary heart disease in a cohort of male US health professionals. Circulation. 2013;128(4):337–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Mekary RA, Giovannucci E, Willett WC, van Dam RM, Hu FB. Eating patterns and type 2 diabetes risk in men: breakfast omission, eating frequency, and snacking. Am J Clin Nutr. 2012;95(5):1182–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Mekary RA, Giovannucci E, Cahill L, Willett WC, van Dam RM, Hu FB. Eating patterns and type 2 diabetes risk in older women: breakfast consumption and eating frequency. Am J Clin Nutr. 2013;98(2):436–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Rong S, Snetselaar LG, Xu G, Sun Y, Liu B, Wallace RBet al. Association of skipping breakfast with cardiovascular and all-cause mortality. J Am Coll Cardiol. 2019;73(16):2025–32. [DOI] [PubMed] [Google Scholar]
  • 38. Witbracht M, Keim NL, Forester S, Widaman A, Laugero K. Female breakfast skippers display a disrupted cortisol rhythm and elevated blood pressure. Physiol Behav. 2015;140:215–21. [DOI] [PubMed] [Google Scholar]
  • 39. Reutrakul S, Hood MM, Crowley SJ, Morgan MK, Teodori M, Knutson KL. The relationship between breakfast skipping, chronotype, and glycemic control in type 2 diabetes. Chronobiol Int. 2014;31(1):64–71. [DOI] [PubMed] [Google Scholar]
  • 40. Jakubowicz D, Wainstein J, Ahren B, Landau Z, Bar-Dayan Y, Froy O. Fasting until noon triggers increased postprandial hyperglycemia and impaired insulin response after lunch and dinner in individuals with type 2 diabetes: a randomized clinical trial. Diabetes Care. 2015;38(10):1820–6. [DOI] [PubMed] [Google Scholar]
  • 41. Vereecken C, Dupuy M, Rasmussen M, Kelly C, Nansel TR, Al Sabbah Het al. Breakfast consumption and its socio-demographic and lifestyle correlates in schoolchildren in 41 countries participating in the HBSC study. Int J Public Health. 2009;54(S2):180–90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. St-Onge MP, Gallagher D. Body composition changes with aging: the cause or the result of alterations in metabolic rate and macronutrient oxidation?. Nutrition. 2010;26(2):152–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Brunner EJ, Kivimäki M. Epidemiology: work-related stress and the risk of type 2 diabetes mellitus. Nat Rev Endocrinol. 2013;9(8):449–50. [DOI] [PubMed] [Google Scholar]
  • 44. Kawakami N, Araki S, Hayashi T, Masumoto T. Relationship between perceived job-stress and glycosylated hemoglobin in white-collar workers. Ind Health. 1989;27(4):149–54. [DOI] [PubMed] [Google Scholar]
  • 45. Bolli GB, Gerich JE. The “dawn phenomenon”—a common occurrence in both non-insulin-dependent and insulin-dependent diabetes mellitus. N Engl J Med. 1984;310(12):746–50. [DOI] [PubMed] [Google Scholar]
  • 46. Rybicka M, Krysiak R, Okopień B. The dawn phenomenon and the Somogyi effect—two phenomena of morning hyperglycaemia. Endokrynol Pol. 2011;62(3):276–84. [PubMed] [Google Scholar]
  • 47. Mody L, Miller DK, McGloin JM, Freeman M, Marcantonio ER, Magaziner Jet al. Recruitment and retention of older adults in aging research. J Am Geriatr Soc. 2008;56(12):2340–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Liu KA, Dipietro Mager NA. Women's involvement in clinical trials: historical perspective and future implications. Pharm Pract (Granada). 2016;14(1):708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. Hernán MA, Hernández-Díaz S. Beyond the intention-to-treat in comparative effectiveness research. Clin Trials. 2012;9(1):48–55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Danaei G, Tavakkoli M, Hernán MA. Bias in observational studies of prevalent users: lessons for comparative effectiveness research from a meta-analysis of statins. Am J Epidemiol. 2012;175(4):250–62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Chiu Y-H, Chavarro JE, Dickerman BA, Manson JE, Mukamal KJ, Rexrode KMet al. Estimating the effect of nutritional interventions using observational data: the American Heart Association's 2020 Dietary Goals and mortality. Am J Clin Nutr. 2021;114(2):690–703. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

nqac087_Supplemental_File

Data Availability Statement

Data described in the article, code book, and analytic code will not be made available because the data are not publicly available from the CHS.


Articles from The American Journal of Clinical Nutrition are provided here courtesy of American Society for Nutrition

RESOURCES